A patient comes to the ER with complaints of shortness of breath, wheezing, a O2 saturation of 92%, respiratory rate of 28, and heart rate of 110. The patient did take a short acting beta 2 agonist prior to coming to the ER. Which drug will the nurses anticipate

A. Albuterol: The patient has already used a short-acting beta-2 agonist, so repeating albuterol may provide some relief but is unlikely to be sufficient for an acute exacerbation with persistent tachypnea and hypoxia. Additional interventions targeting severe airway inflammation may be required. B. Theophylline: Theophylline is a bronchodilator used for long-term asthma management, not for immediate relief in acute severe exacerbations. Its slow onset and narrow therapeutic range make it inappropriate for emergency treatment in this scenario. C. Epinephrine: Epinephrine is indicated in severe acute asthma or anaphylactic reactions when rapid bronchodilation is needed. It works on alpha and beta receptors to reduce airway edema, relax bronchial smooth muscle, and improve oxygenation. In the ER, epinephrine provides fast-acting relief for life-threatening airway obstruction. D. Dexamethasone: Dexamethasone is a corticosteroid that reduces airway inflammation but has a delayed onset of action. While important for sustained management, it does not provide immediate relief for acute shortness of breath or hypoxia and is typically given alongside fast-acting agents.